Biosino Bio-Technology and Science (HKSE:08247) Net Income From Continuing Operations : HK$-21.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Biosino Bio-Technology and Science's net income from continuing operations for the three months ended in Dec. 2023 was HK$-9.3 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-21.3 Mil.

Biosino Bio-Technology and Science Net Income From Continuing Operations Historical Data

The historical data trend for Biosino Bio-Technology and Science's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Net Income From Continuing Operations Chart

Biosino Bio-Technology and Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-127.75

2.56

7.85

20.68

-19.27

Biosino Bio-Technology and Science Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															-3.55	-7.02	-2.02	-2.88	-9.34

Biosino Bio-Technology and Science Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-21.3 Mil.

Biosino Bio-Technology and Science (HKSE:08247) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200

Website

http://www.zhongsheng.com.cn

Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.

Executives

Beijing Enterprises Group Company Limited	2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited	2101 Beneficial owner
Hk Zhixin Investment Co., Ltd.	2101 Beneficial owner
Li Dongfeng	2201 Interest of corporation controlled by you
Yan Kang	2201 Interest of corporation controlled by you
Qiu Zhe Feng	2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Li Yang Yi Xiong	2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines